Pyrrolo[2,3-d]pyrimidin-4-ol | CAS:3680-71-5 99.0% bulk supply

We serve Pyrrolo[2,3-d]pyrimidin-4-ol CAS:3680-71-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Chemical Name:Pyrrolo[2,3-d]pyrimidin-4-ol

CAS.NO:3680-71-5

Synonyms:Pyrrolo[2,3-d]pyrimidin-4-ol

7-Deazahypoxanthine

4-Hydroxypyrrolo[2,3-d]pyrimidine

1H-Pyrrolo[2,3-d]pyrimidin-4(7H)-one

3,7-Dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one

1,7-dihydropyrrolo[2,3-d]pyrimidin-4-one

Physical and Chemical Properties:

Density 1.6±0.1 g/cm3

Boiling Point 473.1±18.0 °C at 760 mmHg

Melting Point 345-348ºC

Molecular Formula C6H5N3O

Molecular Weight 135.123

Flash Point 239.9±21.2 °C

Specification:

Appearance:Brown powder

Assay:≥98.0%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Tofacitinib(CAS:477600-75-2).

Contact us for information like Pyrrolo[2,3-d]pyrimidin-4-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,7-dihydropyrrolo[2,3-d]pyrimidin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-Deazahypoxanthine Use and application,Pyrrolo[2,3-d]pyrimidin-4-ol technical grade,usp/ep/jp grade.

Related News: “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”Trimethylsilanol manufacturer “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”1-Bromo-4-iodobenzene supplier Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.F-Ara-A vendor This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.”Traditional medicine is a treasure of Chinese civilization embodying the wisdom of the nation and its people,” Xi said at the meeting in Beijing.